Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1136)	4/18/2002 7:23:33 PM
From: JMarcus	Read Replies (1) \| Respond to of 2243

Rick, I know you don't think much of AVXT's autologous cancer vaccine (a new and improved version of which was in the news today, pumping the stock up 28%), but isn't it intriguing that they own Génopoïétic, one of the lead firms involved in the Bubble Boy cure, a huge first for gene therapy? Surprisingly, AVXT didn't issue a press release taking credit for the Bubble Boy cure. I just posted a backgrounder on the topic at Message 17352048 Marc